All About Us

Kadesh Sciences International (KSi) is an indigenous company founded in 2020 by a consortium of experts drawn from the academia, healthcare sector, regulatory agency and local investigators. These team have been at the core of international multi-site randomized clinical trials in the past 10 years and have realized the need to advance human research, clinical trial development and infrastructure in the Nigerian healthcare industry and Academia. Their goal is provide a reliable platform to support hospitals (sites)  and communities to participate and benefit from both local and global clinical trials and analytic studies.  

Nigeria has a vast population of over 200 million with a highly skilled and intelligent health workforce; however; with limited opportunities and exposure in research. Africa as we know, most especially the sub-Saharan region is grossly under-represented in clinical trials. KSi goal is to take concrete steps  to change that narrative by laying a foundation in place for clinicians and vast patient populations to benefit from international research studies in various areas of disease interest by attracting sponsors with a promise to deliver quality data and implement studies according to international best practice standards and ICH-GCP.

This will be achieved by closely  supporting studies received through the KSi platform from inception to finish, while investigators remain fully affiliated to their institutions in every way.  

​

Africa is the next big field for advancing clinical research in the future and we are poised to contribute to that future by shaping the processes early through an integrated, efficient and standardized ecosystem to improve patient outcomes, diffusion of scientific knowledge,  fulfill sponsor expectation and the growth of research.